[EN] TEAD INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE TEAD ET LEURS UTILISATIONS
申请人:IKENA ONCOLOGY INC
公开号:WO2020243423A1
公开(公告)日:2020-12-03
The present invention provides compounds, compositions thereof, and methods of using the same.
本发明提供了化合物、其组合物以及使用它们的方法。
Use of (Cyclopentadienone)iron Tricarbonyl Complexes for C–N Bond Formation Reactions between Amines and Alcohols
作者:Thomas J. Brown、Madeleine Cumbes、Louis J. Diorazio、Guy J. Clarkson、Martin Wills
DOI:10.1021/acs.joc.7b01990
日期:2017.10.6
of a series of (cyclopentadienone)iron tricarbonyl complexes to “borrowing hydrogen” reactionsbetweenamines and alcohols was completed in order to assess their catalytic activity. The electronic variation of the aromatic groups flanking the C═O of the cyclopentadienone influenced the efficiency of the reactions; however, in other cases, the Knölker catalyst 1, containing trimethylsilyl groups flanking
An Expedient Three-Component Synthesis of Tertiary Benzylamines
作者:Erwan Le Gall、Alexandre Decompte、Thierry Martens、Michel Troupel
DOI:10.1055/s-0029-1217108
日期:2010.1
A Mannich-like zinc-mediated three-component reaction of aromatic halides, amines, and paraformaldehyde is described. This procedure, which involves the in situ formation of arylzinc reagents, allows the straightforward synthesis of a range of functionalized tertiary benzylamines.
SUBSTITUTED BENZYLAMINES AS CYP2A INHIBITORS AND USES THEREOF TO TREAT NICOTINE DEPENDENCE
申请人:Ghosheh Omar
公开号:US20090137653A1
公开(公告)日:2009-05-28
This invention is directed to substituted benzylamines which are useful as inhibitors of the CYP2A6 enzyme. Pharmaceutical compositions comprising the compounds and methods of using the compounds to treat nicotine dependence are also disclosed.